64Cu loaded liposomes as positron emission tomography imaging agents

Biomaterials

Volumn 32, Issue 9, 2011, Pages 2334-2341

  Petersen, Anncatrine L ^a   Binderup, Tina ^b,c   Rasmussen, Palle ^a   Henriksen, Jonas R ^a   Elema, Dennis R ^a   Kjær, Andreas ^b,c   Andresen, Thomas L ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Diagnostics; Liposome; Positron emission tomography (PET); Remote loading; Tumor accumulation

Indexed keywords

DIAGNOSTICS; EFFICIENT METHOD; HIGH RESOLUTION IMAGE; HYDROXYQUINOLINES; IMAGING AGENT; IN-VIVO; IN-VIVO IMAGING; NANOMEDICINES; PET IMAGING; POSITRON EMISSION; REMOTE LOADING; THERAPEUTIC APPLICATION; TISSUE DISTRIBUTIONS; TUMOR ACCUMULATION;

ELECTRONS; LIPOSOMES; LOADING; MEDICAL NANOTECHNOLOGY; ORGANIC COMPOUNDS; PHOSPHOLIPIDS; POSITRONS; TUMORS;

POSITRON EMISSION TOMOGRAPHY;

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID CU 64; 2 HYDROXYQUINOLINE CU 64; COPPER 64; IONOPHORE; LIPOSOME; RADIOPHARMACEUTICAL AGENT; TRIENTINE; UNCLASSIFIED DRUG; COPPER; DIAGNOSTIC AGENT; LIGAND;

ANIMAL EXPERIMENT; ARTICLE; COLON ADENOCARCINOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG STABILITY; FEMALE; HEART LEFT VENTRICLE; HUMAN; HUMAN CELL; IMAGE QUALITY; IN VIVO STUDY; ISOTHERMAL TITRATION CALORIMETRY; LIVER; MOUSE; MUSCLE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SPLEEN; ANIMAL; CALORIMETRY; CELL STRAIN HT29; CHEMISTRY; METHODOLOGY; NEOPLASM; PARTICLE SIZE; SCINTISCANNING; STATIC ELECTRICITY; TISSUE DISTRIBUTION;

MUS;

ANIMALS; CALORIMETRY; COPPER RADIOISOTOPES; HT29 CELLS; HUMANS; LIGANDS; LIPOSOMES; MICE; NEOPLASMS; PARTICLE SIZE; POSITRON-EMISSION TOMOGRAPHY; STATIC ELECTRICITY; TISSUE DISTRIBUTION;

EID: 78951482499     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.11.059     Document Type: Article

References (36)

1. Goins B.A. Radiolabeled lipid nanoparticles for diagnostic imaging. Expert Opin Med Diagn 2008, 2:853-873.
2. Phelps M.E., Hoffman E.J., Mullani N.A., Ter-Pogossian M.M. Application of annihilation coincidence detection to transaxial reconstruction tomography. J Nucl Med 1975, 16:210-214.
3. Weissleder R. Molecular imaging in cancer. Science 2006, 312:1168-1171.
4. Rohren E.M., Turkington T.G., Coleman R.E. Clinical applications of PET in oncology. Radiology 2004, 231:305-332.
5. Gambhir S.S. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002, 2:683-693.
6. Jerusalem G., Hustinx R., Beguin Y., Fillet G. PET scan imaging in oncology. Eur J Cancer 2003, 39:1525-1534.
7. Bangham A.D. Surrogate cells or Trojan horses. The discovery of liposomes. Bioessays 1995, 17:1081-1088.
8. Shokeen M., Anderson C.J. Molecular imaging of cancer with copper-64 radiopharmacueticals and positron emission tomography (PET). Acc Chem Res 2009, 42:832-841.
9. 60Cu-ATSM in cancer of the uterine cervix. J Nucl Med 2008, 49:1177-1182.
10. Knogler K., Grünberg J., Zimmermann K., Cohrs S., Honer M., Ametamey S., et al. Copper-67 radioimmunotherapy and growth inhibition by anti-L1-cell adhesion molecule monoclonal antibodies in a therapy model of ovarian cancer metastasis. Clin Cancer Res 2007, 13:603-611.
11. 67Cu. Proc Natl Acad Sci 1996, 93:6814-6818.
12. 64Cu-SarAr immunoconjugates. Proc Natl Acad Sci 2007, 104:17489-17493.
13. Gambhir S.S., Herschman H.R., Cherry S.R., Barrio J.R., Satyamurthy N., Toyokuni T., et al. Imaging transgene expression with radionuclide imaging technologies. Neoplasia 2000, 2:118-138.
14. Willmann J.K., Bruggen N.V., Dinkelborg L.M., Gambhir S.S. Molecular imaging in drug development. Nat Rev Drug Discov 2008, 7:591-607.
15. Adonai N., Nguyen K.N., Walsh J., Lyer M., Toyokuni T., Phelps M.E., et al. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci USA 2002, 99:3030-3035.
16. 64Cu for positron emission tomography (PET) imaging. Bioconjug Chem 2008, 19:2577-2584.
17. Oku N., Tokudome Y., Tsukada H., Okada S. Real-time analysis of liposomal trafficking in tumor-bearing mice by use of positron emission tomography. Biochim Biophys Acta 1995, 1238:86-90.
18. 18F]FDP). Nucl Med Biol 2007, 34:165-171.
19. 18F]-radiolabeling preformed liposomes and determination of liposomal trafficking by positron emission tomography. J Med Chem 2007, 50:6454-6457.
20. Hwang K.J., Merriam J.E., Beaumier P.L., Luk K.-F.S. Encapsulation, with high efficiency, of radioactive metal ions in liposomes. Biochim Biophys Acta 1982, 716:101-109.
21. Mauk M.R., Gamble R.C., Baldeschwieler J.D. Targeting of lipid vesicles: Specificity of carbohydrate receptor analogues for leukocytes in mice. Proc Natl Acad Sci USA 1980, 77:4030-4034.
22. Phillips W.T., Rudolph A.S., Goins B., Timmons J.H., Klipper R., Blumhardt R. A simple method for producing a technetium-99m-labeled liposome which is stable in vivo. Nucl Med Biol 1992, 19:539-547.
23. Phillips W.T., Goins B.A., Bao A. Radioactive liposomes. Rev Nanomed Nanobiotechnol 2009, 1:69-83.
24. Goins B.A., Phillips W.T. The use of scintigraphic imaging as a tool in the development of liposome formulations. Prog Lipid Res 2001, 40:95-123.
25. Huang S.K., Stauffer P.R., Hong K., Guo J.W.H., Phillips T.L., Huang A., et al. Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. Cancer Res 1994, 54:2186-2191.
26. Allen T.M., Cullis P.R. Drug delivery systems: entering the mainstream. Science 2004, 303:1818-1822.
27. Jones-Wilson T.M., Deal K.A., Anderson C.J., McCarthy D.W., Kovacs Z., Matekaitis R.J., et al. The in vivo behaviour of copper-64-labeled azamacrocyclic complexes. Nucl Med Biol 1998, 25:523-530.
28. Papahadjopoulos D., Allen T.M., Gabizon A., Mayhew E., Matthay K., Huang S.K., et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci 1991, 88:11460-11464.
29. 18F-FDG PET studies. J Nucl Med 2006, 47:945-949.
30. Goins B., Klipper R., Rudolph A.S., Phillips W.T. Use of technetium-99m-liposomes in tumor imaging. J Nucl Med 1994, 35:1491-1498.
31. Gabizon A., Catane R., Uziely B., Kaufman G., Safra T., Barenholz Y., et al. A pilot study of doxorubicin encapsulated in long-circulating (stealth) liposomes (S-DOX) in cancer patients. Proc Am Soc Clin Oncol 1992, 11:124.
32. Philips W.T. Delivery of gamma-imaging agents by liposomes. Adv Drug Deliv Rev 1999, 37:13-32.
33. 111In-labeled polychelating-polymer-containing immunoliposomes. Mol Pharm 2006, 3:525-530.
34. Oh P., Li Y., Yu J., Durr E., Krasinska K.M., Carver L.A., et al. Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 2004, 429:629-635.
35. Hoffman J.A., Giraudo E., Singh M., Zhang L., Inoue M., Porkka K., et al. Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. Cancer Cell 2003, 4:383-391.
36. Ruoslahti E. Specialization of tumour vasculature. Nat Rev Cancer 2002, 2:83-90.